Tuesday, June 23, 2026
ADVT 
International

She Didn't Appear Drunk: Indian-Origin Man In UK Faces Trial For Rape

IANS, 29 Jun, 2018 01:10 PM
    A Indian-origin finance consultant from north London is on trial for allegedly raping an 18-year-old woman after a night out drinking with his colleagues.
     
     
    Sanjay Naker denies three charges of rape, one count of attempted rape, one charge of assault by penetration, and a count of sexual assault as the trial got underway at Inner London Crown Court this week.
     
     
    The married 28-year-old is accused of carrying the woman over his shoulder after she was denied entry into a nightclub in central London for being drunk and raped her in an alleyway.
     
     
    The jury was told that the last thing the unnamed woman remembers was standing in the smoking area with her cousin at the club and then staring at a brick wall in the alley.
     
     
    Naker told police the sex was consensual and said the woman had not appeared drunk. He admitted later searching online for a definition of the word "rape" but said it reassured him he had done nothing wrong.
     
     
    Showing the jury CCTV footage from the incident in March last year, prosecutor Neena Crinnion said, "He (Naker) has managed to manoeuvre her on to his back, into a piggyback position, and he is off across the road and down towards the passageway. The CCTV shows she appears to be slumped over his back, not really maintaining any grip".
     
     
    Jurors watched footage of the woman falling from Naker's back and banging her head on the ground, the 'Evening Standard' reports. Naker is then accused of "dragging" her further along the alleyway to a "filthy corner".
     
     
    The prosecution alleges that Naker forced the "extremely drunk" woman to perform sex acts on him before trying to have sex with her.
     
     
    Naker denies the allegations as the trial remains ongoing at the London court.

    MORE International ARTICLES

    Reluctantly, Obama Embracing His Role As The Anti-Trump

    WASHINGTON — He won't be on November's ballot, but President Barack Obama is slowly embracing his role as the anti-Trump, taking on the Republican front-runner in ways that no other Democrat can.

    Reluctantly, Obama Embracing His Role As The Anti-Trump

    Rare Blue Diamond Sets New Record At Sotheby's Auction

    Rare Blue Diamond Sets New Record At Sotheby's Auction
    A rare blue diamond bucked the recent downturn in the auction market when it was sold for $30.8 million at Sotheby's, setting a new record.

    Rare Blue Diamond Sets New Record At Sotheby's Auction

    9-Year-Old Reporter Defends Homicide Coverage After Backlash

    9-Year-Old Reporter Defends Homicide Coverage After Backlash
    A 9-year-old reporter who wrote about a suspected murder in her small Pennsylvania town is defending herself after some locals lashed out about a young girl covering violent crimes.

    9-Year-Old Reporter Defends Homicide Coverage After Backlash

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes
    WHISTLER, B.C. — The Whistler Blackcomb mountain resort is planning a renaissance over the next few years that would include real estate developments in the later phases and a price tag of about $345 million.

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden
    The former U.S. intelligence contractor said Tuesday that the so-called Panama Papers, which were given to journalists by an anonymous source, demonstrate that "change doesn't happen by itself."

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden

    Allergan, Pfizer Call Off Proposed $160b Merger

    Allergan, Pfizer Call Off Proposed $160b Merger
    The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland — on paper — to reduce its tax bill.

    Allergan, Pfizer Call Off Proposed $160b Merger